Evaluation of the genomic alterations in the androgen receptor gene during treatment with high-dose testosterone for metastatic castrate-resistant prostate cancer

Introduction: Castration resistant prostate cancer (CRPC) has been characterized by a reactivation of the androgen receptor (AR) signaling pathway via alterations in androgen metabolism and AR aberrations. High-dose testosterone (HDT) is emerging as an active treatment in metastatic CRPC, however, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Moses, Marcus, Koksal, Ulkuhan, Ledet, Elisa, Manogue, Charlotte, Cotogno, Patrick, Lewis, Brian, Layton, Jodi, Sartor, A. Oliver, Barata, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967778/
https://www.ncbi.nlm.nih.gov/pubmed/32002120
http://dx.doi.org/10.18632/oncotarget.27408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967778/
https://www.ncbi.nlm.nih.gov/pubmed/32002120
http://dx.doi.org/10.18632/oncotarget.27408

Ejemplares similares